Amirav Israel, Wallmeier Julia, Loges Niki T, Menchen Tabea, Pennekamp Petra, Mussaffi Huda, Abitbul Revital, Avital Avraham, Bentur Lea, Dougherty Gerard W, Nael Elias, Lavie Moran, Olbrich Heike, Werner Claudius, Kintner Chris, Omran Heymut
Ziv Medical Center, Faculty of Medicine, Bar IIan University, Safed 13100, Israel.
Department of General Pediatrics, University Children's Hospital Muenster, Muenster, 48149, Germany.
Hum Mutat. 2016 Apr;37(4):396-405. doi: 10.1002/humu.22957. Epub 2016 Feb 4.
Reduced generation of multiple motile cilia (RGMC) is a novel chronic destructive airway disease within the group of mucociliary clearance disorders with only few cases reported. Mutations in two genes, CCNO and MCIDAS, have been identified as a cause of this disease, both leading to a greatly reduced number of cilia and causing impaired mucociliary clearance. This study was designed to identify the prevalence of CCNO mutations in Israel and further delineate the clinical characteristics of RGMC. We analyzed 170 families with mucociliary clearance disorders originating from Israel for mutations in CCNO and identified two novel mutations (c.165delC, p.Gly56Alafs*38; c.638T>C, p.Leu213Pro) and two known mutations in 15 individuals from 10 families (6% prevalence). Pathogenicity of the missense mutation (c.638T>C, p.Leu213Pro) was demonstrated by functional analyses in Xenopus. Combining these 15 patients with the previously reported CCNO case reports revealed rapid deterioration in lung function, an increased prevalence of hydrocephalus (10%) as well as increased female infertility (22%). Consistent with these findings, we demonstrate that CCNO expression is present in murine ependyma and fallopian tubes. CCNO is mutated more frequently than expected from the rare previous clinical case reports, leads to severe clinical manifestations, and should therefore be considered an important differential diagnosis of mucociliary clearance disorders.
多纤毛运动减少(RGMC)是黏液纤毛清除障碍组中的一种新型慢性破坏性气道疾病,仅有少数病例报道。已确定CCNO和MCIDAS这两个基因的突变是该疾病的病因,二者均导致纤毛数量大幅减少并引起黏液纤毛清除功能受损。本研究旨在确定以色列CCNO突变的患病率,并进一步描述RGMC的临床特征。我们分析了170个来自以色列的黏液纤毛清除障碍家庭的CCNO突变情况,在10个家庭的15名个体中鉴定出两个新突变(c.165delC,p.Gly56Alafs*38;c.638T>C,p.Leu213Pro)和两个已知突变(患病率6%)。通过非洲爪蟾的功能分析证实了错义突变(c.638T>C,p.Leu213Pro)的致病性。将这15例患者与先前报道的CCNO病例报告相结合,发现肺功能迅速恶化、脑积水患病率增加(10%)以及女性不孕症患病率增加(22%)。与这些发现一致,我们证明CCNO在小鼠室管膜和输卵管中表达。CCNO的突变频率高于先前罕见临床病例报告的预期,会导致严重的临床表现,因此应被视为黏液纤毛清除障碍的重要鉴别诊断。